Decreased expression of catalase mRNA in thyroid anaplastic carcinoma

被引:20
|
作者
Hasegawa, Y
Takano, T
Miyauchi, A
Matsuzuka, F
Yoshida, H
Kuma, K
Amino, N
机构
[1] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan
[2] Kuma Hosp, Kobe, Hyogo, Japan
关键词
catalase; superoxide dismutase; mRNA; thyroid; anaplastic carcinoma; MANGANESE SUPEROXIDE-DISMUTASE; MESSENGER-RNA; ANTIOXIDANT DEFENSE; CDNA; MECHANISM; SEQUENCE; TUMORS; CELLS;
D O I
10.1093/jjco/hyg009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: A decreased expression of glutathione peroxidase mRNA, an antioxidant enzyme, was previously observed in thyroid anaplastic carcinomas. Methods: To clarify the expression of anti oxidant-related enzymes in thyroid anaplastic carcinomas, the expression levels of catalase, copper and zinc superoxide dismutase and manganese superoxide dismutase mRNA in 85 benign and malignant thyroid tissues were measured by means of real-time quantitative reverse transcription-polymerase chain reaction. Results: Decreased expression levels of catalase and copper and zinc superoxide dismutase mRNAs, but not manganese mRNA, were observed in five anaplastic carcinomas compared with normal thyroid tissues and differentiated tumors. Conclusion: These results suggest the possibility that anaplastic carcinoma cells are more likely to suffer damage by oxygen free radicals than normal thyroid cells or differentiated tumor cells.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [31] Anaplastic thyroid carcinoma in Ireland
    Lennon, P.
    Deady, S.
    Healy, M. L.
    Kinsella, J.
    Timon, C. I.
    Hill, A. J.
    O'Neill, J. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S191 - S191
  • [32] Imaging of Anaplastic Thyroid Carcinoma
    Ahmed, S.
    Ghazarian, M. P.
    Cabanillas, M. E.
    Zafereo, M. E.
    Williams, M. D.
    Vu, T.
    Schomer, D. F.
    Debnam, J. M.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (03) : 547 - 551
  • [33] Anaplastic thyroid carcinoma: An overview
    Cornett W.R.
    Sharma A.K.
    Day T.A.
    Richardson M.S.
    Hoda R.S.
    van Heerden J.A.
    Fernandes J.K.
    Current Oncology Reports, 2007, 9 (2) : 152 - 158
  • [34] Immunotherapy for Anaplastic Thyroid Carcinoma
    Lim, Annette M.
    Solomon, Benjamin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (23) : 2603 - +
  • [35] Treatment of anaplastic thyroid carcinoma
    Rao, S. S.
    Haughey, B. H.
    Grigsby, P. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S416 - S416
  • [36] Anaplastic Thyroid Carcinoma Survival
    Petri E. Voutilainen
    Markku Multanen
    Reijo K. Haapiainen
    Ari K. Leppäniemi
    Arto H. Sivula
    World Journal of Surgery, 1999, 23 : 975 - 979
  • [37] Iodine and Anaplastic Thyroid Carcinoma
    Smyth, Peter P. A.
    THYROID, 2010, 20 (06) : 581 - 582
  • [38] OSTEOGENIC ANAPLASTIC CARCINOMA OF THE THYROID
    PASCALVIGNERON, V
    SCHNEEGANS, O
    WERYHA, G
    FLOQUET, J
    OLIVIER, P
    MAYOT, D
    LECLERE, J
    THYROID, 1993, 3 (04) : 319 - 323
  • [39] Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid
    Untch, Brian R.
    Olson, John A., Jr.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 15 (03) : 661 - +
  • [40] Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma
    Asakawa, H
    Kobayashi, T
    Komoike, Y
    Maruyama, H
    Nakano, Y
    Tamaki, Y
    Matsuzawa, Y
    Monden, M
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2757 - 2762